
IXICO PLC — Investor Relations & Filings
IXICO PLC is a clinical research and data analytics company specializing in neuroscience. It provides neuroimaging and digital biomarker analytics to biopharmaceutical firms conducting clinical trials for neurological disorders. The company utilizes its proprietary, AI-driven technology platform to manage and analyze complex imaging and digital health data. This platform deploys disease-specific algorithms to generate reliable clinical data and precision insights, aiming to accelerate research and development decision-making, de-risk clinical studies, and support the advancement of new therapies for conditions such as Alzheimer's and Huntington's disease.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| IXICO Updates AI Neuroimaging Platform | 2026-05-12 | English | |
| Holding(s) in Company | 2026-04-28 | English | |
| Holding(s) in Company | 2026-04-28 | English | |
| Holding(s) in Company | 2026-04-28 | English | |
| Holding(s) in Company | 2026-04-28 | English | |
| Holding(s) in Company | 2026-04-27 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45118804 | IXICO Updates AI Neuroimaging Platform | 2026-05-12 | English | ||
| 38022136 | Holding(s) in Company | 2026-04-28 | English | ||
| 38012681 | Holding(s) in Company | 2026-04-28 | English | ||
| 37961295 | Holding(s) in Company | 2026-04-28 | English | ||
| 37947832 | Holding(s) in Company | 2026-04-28 | English | ||
| 37503919 | Holding(s) in Company | 2026-04-27 | English | ||
| 37503851 | Holding(s) in Company | 2026-04-27 | English | ||
| 37503840 | Holding(s) in Company | 2026-04-27 | English | ||
| 37461089 | Holding(s) in Company | 2026-04-27 | English | ||
| 37400009 | Holding(s) in Company | 2026-04-27 | English | ||
| 36162273 | Holding(s) in Company | 2026-04-24 | English | ||
| 35238680 | Issue of Equity | 2026-04-22 | English | ||
| 34696718 | Trading Update | 2026-04-21 | English | ||
| 33102062 | Retail Offer | 2026-03-31 | English | ||
| 33101907 | Placings and Subscription | 2026-03-31 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for IXICO PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Marvel Biosciences Corp.
Developing transformative treatments for complex neurologic…
|
MRVL | CA | Professional, scientific and te… |
|
Matinas BioPharma Holdings, Inc.
Biopharma firm developing therapeutics using its Lipid Nano…
|
MTNB | US | Professional, scientific and te… |
|
Matricelf Ltd.
Develops autologous, patient-specific tissue implants for r…
|
MTLF | IL | Professional, scientific and te… |
|
MAXCYTE, INC.
A cell-engineering company with a platform for developing c…
|
MXCT | US | Professional, scientific and te… |
|
Medicenna Therapeutics Corp.
A clinical-stage immunotherapy company developing novel eng…
|
MDNA | CA | Professional, scientific and te… |
|
Medicofarma Biotech Spolka Akcyjna
R&D company developing innovative medicines, medical device…
|
MDB | PL | Professional, scientific and te… |
|
Medigene AG
Develops TCR-guided immunotherapies for cancer; currently i…
|
MDG1 | DE | Professional, scientific and te… |
|
Medizen Humancare Inc Co., Ltd
A research company specializing in genomic analysis for per…
|
236340 | KR | Professional, scientific and te… |
|
Medpace Holdings, Inc.
A global CRO providing Phase I-IV clinical development for …
|
MEDP | US | Professional, scientific and te… |
|
MegaPro Biomedical Co. Ltd.
A clinical-stage biotech developing nanomedicines for oncol…
|
— | MY | Professional, scientific and te… |
IXICO PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7723/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7723 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7723 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7723 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7723}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for IXICO PLC (id: 7723)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.